Company Focus

Novartis

Latest Novartis News

Novartis scraps osteoarthritis candidate QUC398
Biotechnology
Swiss pharma major Novartis has discontinued development of its experimental treatment QUC398 for knee osteoarthritis, ending hopes for a new therapy in the anti-ADAMTS-5 class.   17 April 2025


Insights

Company Spotlight

Latest News & Features of interest to Novartis

Latest Ones To Watch News

Florida biopharma Ligand Pharmaceuticals subsidiary Pelthos Therapeutics is to merge with Channel Therapeutics, a developer of non-opioid pain treatments.   17 April 2025

More in M&A >


Ones to Watch Companies

Reset all filters
Refine Search